Published in Lancet on May 07, 2015
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Atrial Fibrillation Begets Heart Failure and Vice Versa: Temporal Associations and Differences in Preserved Versus Reduced Ejection Fraction. Circulation (2016) 1.76
Bariatric Surgery and the Risk of New-Onset Atrial Fibrillation in Swedish Obese Subjects. J Am Coll Cardiol (2016) 1.45
Taking the pulse of atrial fibrillation. Lancet (2015) 1.40
Genetic Obesity and the Risk of Atrial Fibrillation- Causal Estimates from Mendelian Randomization. Circulation (2016) 1.00
Atrial fibrillation in women: epidemiology, pathophysiology, presentation, and prognosis. Nat Rev Cardiol (2016) 0.89
Expert consensus document: Defining the major health modifiers causing atrial fibrillation: a roadmap to underpin personalized prevention and treatment. Nat Rev Cardiol (2015) 0.87
A Simple and Portable Algorithm for Identifying Atrial Fibrillation in the Electronic Medical Record. Am J Cardiol (2015) 0.85
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF. Eur Heart J (2016) 0.84
Cohort Profile: The Framingham Heart Study (FHS): overview of milestones in cardiovascular epidemiology. Int J Epidemiol (2015) 0.83
Evaluation of the Association Between Retinal Vein Occlusion and the Risk of Atrial Fibrillation Development: A 12-Year, Retrospective Nationwide Cohort Study. Sci Rep (2016) 0.82
Impact of Awareness and Patterns of Nonhospitalized Atrial Fibrillation on the Risk of Mortality: The Reasons for Geographic And Racial Differences in Stroke (REGARDS) Study. Clin Cardiol (2016) 0.82
Genomics of Atrial Fibrillation. Curr Cardiol Rep (2016) 0.80
The Future of Arrhythmias and Electrophysiology. Circulation (2016) 0.79
Non-vitamin K antagonist oral anticoagulation usage according to age among patients with atrial fibrillation: Temporal trends 2011-2015 in Denmark. Sci Rep (2016) 0.79
A comparison of the CHARGE-AF and the CHA2DS2-VASc risk scores for prediction of atrial fibrillation in the Framingham Heart Study. Am Heart J (2016) 0.78
Increasing atrial fibrillation prevalence in acute ischemic stroke and TIA. Neurology (2016) 0.77
Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study. Am Heart J (2016) 0.77
No Decline in the Risk of Stroke Following Incident Atrial Fibrillation Since 2000 in the Community: A Concerning Trend. J Am Heart Assoc (2016) 0.77
BCR Signaling Inhibitors: an Overview of Toxicities Associated with Ibrutinib and Idelalisib in Patients with Chronic Lymphocytic Leukemia. Mediterr J Hematol Infect Dis (2016) 0.77
Atrial flutter: Clinical risk factors and adverse outcomes in the Framingham Heart Study. Heart Rhythm (2015) 0.76
Comorbidity of atrial fibrillation and heart failure. Nat Rev Cardiol (2015) 0.76
Electronic Alert System for Improving Stroke Prevention Among Hospitalized Oral-Anticoagulation-Naïve Patients With Atrial Fibrillation: A Randomized Trial. J Am Heart Assoc (2016) 0.75
Long-Term Exposure to Traffic-Related Air Pollution and Risk of Incident Atrial Fibrillation: A Cohort Study. Environ Health Perspect (2016) 0.75
Right Ventricular Structure and Function Are Associated With Incident Atrial Fibrillation: MESA-RV Study (Multi-Ethnic Study of Atherosclerosis-Right Ventricle). Circ Arrhythm Electrophysiol (2017) 0.75
Association between Heat Shock Protein-60 and Development of Atrial Fibrillation: Results from the Multi-Ethnic Study of Atherosclerosis (MESA). Pacing Clin Electrophysiol (2016) 0.75
Association Between the Left Atrial and Left Atrial Appendages Systole Strain Rate in Patients with Atrial Fibrillation. Med Sci Monit (2016) 0.75
Clinical presentation, management, and outcomes in the Indian Heart Rhythm Society-Atrial Fibrillation (IHRS-AF) registry. Indian Heart J (2016) 0.75
Trajectories of Risk Factors and Risk of New-Onset Atrial Fibrillation in the Framingham Heart Study. Hypertension (2016) 0.75
Atrial Fibrillation and Risk of Dementia/Cognitive Decline. J Atr Fibrillation (2016) 0.75
The burden of proof: The current state of atrial fibrillation prevention and treatment trials. Heart Rhythm (2017) 0.75
Association of Atrial Fibrillation and Cancer. JAMA Cardiol (2016) 0.75
Stroke as the Initial Manifestation of Atrial Fibrillation: The Framingham Heart Study. Stroke (2017) 0.75
Atrial Fibrillation is Associated With Morphine Treatment in Female Breast Cancer Patients: A Retrospective Population-Based Time-Dependent Cohort Study. Medicine (Baltimore) (2016) 0.75
Comparison of Approaches for Stroke Prophylaxis in Patients with Non-Valvular Atrial Fibrillation: Network Meta-Analyses of Randomized Controlled Trials. PLoS One (2016) 0.75
Serum brain-derived neurotrophic factor and risk of atrial fibrillation. Am Heart J (2016) 0.75
The Predictive Role of Inflammatory Biomarkers in Atrial Fibrillation as Seen through Neutrophil-Lymphocyte Ratio Mirror. J Biomark (2016) 0.75
Clinical and Economic Implications of AF Related Stroke. J Atr Fibrillation (2016) 0.75
Methylome-wide Association Study of Atrial Fibrillation in Framingham Heart Study. Sci Rep (2017) 0.75
Bleeding-related admissions in patients with atrial fibrillation receiving antithrombotic therapy: results from the Tasmanian Atrial Fibrillation (TAF) study. Eur J Clin Pharmacol (2017) 0.75
Association between KCNE1 G38S gene polymorphism and risk of atrial fibrillation: A PRISMA-compliant meta-analysis. Medicine (Baltimore) (2017) 0.75
Sex hormones and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA). Endocrine (2017) 0.75
Temporal Trends in Incidence, Prevalence, and Mortality of Atrial Fibrillation in Primary Care. J Am Heart Assoc (2017) 0.75
Usefulness of Atrial Premature Complexes on Routine Electrocardiogram to Determine the Risk of Atrial Fibrillation (from the REGARDS Study). Am J Cardiol (2017) 0.75
Review of screening studies for atrial fibrillation in rural populations of 11 countries. Proc (Bayl Univ Med Cent) (2017) 0.75
Risk Factors and Etiology of Young Ischemic Stroke Patients in Estonia. Stroke Res Treat (2017) 0.75
Atrial Fibrillation in Heart Failure: a Therapeutic Challenge of Our Times. Korean Circ J (2017) 0.75
Effect of a combined education and eHealth programme on the control of oral anticoagulation patients (PORTALS study): a parallel cohort design in Dutch primary care. BMJ Open (2017) 0.75
High molecular weight fibroblast growth factor-2 as a promising prognostic biomarker to predict the occurrence of heart failure in atrial fibrillation patients. Heart Vessels (2017) 0.75
[Ablation for atrial fibrillation in the elderly]. Herzschrittmacherther Elektrophysiol (2017) 0.75
When Is the Optimal Timing of Surgical Intervention for Severe Functional Tricuspid Regurgitation? Case Rep Cardiol (2017) 0.75
Atrial Fibrillation: Epidemiology, Pathophysiology, and Clinical Outcomes. Circ Res (2017) 0.75
Age-Specific Vascular Risk Factor Profiles According to Stroke Subtype. J Am Heart Assoc (2017) 0.75
Gender differences in fibrosis remodeling in patients with long-standing persistent atrial fibrillation. Oncotarget (2017) 0.75
Integrated care of patients with atrial fibrillation: the 2016 ESC atrial fibrillation guidelines. Heart (2017) 0.75
Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health Nations Health (1951) 20.27
Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation (1998) 19.93
Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med (2007) 16.95
US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008. JAMA (2010) 13.94
Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence. Circulation (2006) 11.78
Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA (1994) 11.63
Subclinical atrial fibrillation and the risk of stroke. N Engl J Med (2012) 11.11
The Framingham Offspring Study. Design and preliminary data. Prev Med (1975) 10.53
Long-term trends in the incidence of and survival with heart failure. N Engl J Med (2002) 10.37
Burden of valvular heart diseases: a population-based study. Lancet (2006) 8.94
National and regional trends in heart failure hospitalization and mortality rates for Medicare beneficiaries, 1998-2008. JAMA (2011) 5.16
Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation (2013) 4.60
Estimation of total incremental health care costs in patients with atrial fibrillation in the United States. Circ Cardiovasc Qual Outcomes (2011) 3.25
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007. Circ Cardiovasc Qual Outcomes (2012) 2.61
Trends in the prevalence of hypertension, antihypertensive therapy, and left ventricular hypertrophy from 1950 to 1989. N Engl J Med (1999) 2.53
Estimates of current and future incidence and prevalence of atrial fibrillation in the U.S. adult population. Am J Cardiol (2013) 2.29
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060. Eur Heart J (2013) 2.17
Trends in the incidence and prevalence of atrial fibrillation in Iceland and future projections. Europace (2011) 2.06
Comparison of 2 methods for calculating adjusted survival curves from proportional hazards models. JAMA (2001) 2.05
Regression of electrocardiographic left ventricular hypertrophy and decreased incidence of new-onset atrial fibrillation in patients with hypertension. JAMA (2006) 2.00
Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA (2014) 1.97
All-cause mortality in 272,186 patients hospitalized with incident atrial fibrillation 1995-2008: a Swedish nationwide long-term case-control study. Eur Heart J (2013) 1.92
Increased atrial fibrillation mortality: United States, 1980-1998. Am J Epidemiol (2002) 1.63
Increased mortality in paroxysmal atrial fibrillation: report from the Stockholm Cohort-Study of Atrial Fibrillation (SCAF). Eur Heart J (2007) 1.10
Trends in anticoagulation for atrial fibrillation in the U.S.: an analysis of the national ambulatory medical care survey database. J Am Coll Cardiol (2007) 1.09
Trends in incidence and mortality in the hospital diagnosis of atrial fibrillation or flutter in Denmark, 1980-1999. Int J Cardiol (2005) 1.04